Clinical Trials Logo

Clinical Trial Summary

By observing the difference of plasma homovanillic acid concentrations and brain electrical consciousness monitoring Narcotrend index, study the possible mechanism of influencing Etomidate induced myoclonus with Dexmedetomidine pretreatment during general anesthesia induction period.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02518789
Study type Interventional
Source Tang-Du Hospital
Contact
Status Not yet recruiting
Phase Phase 4
Start date September 2015
Completion date September 2016

See also
  Status Clinical Trial Phase
Completed NCT04235452 - Electrophysiological Characteristics and Anatomical Differentiation of Epileptic and Non-epileptic Myoclonus.
Completed NCT00001667 - Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases N/A
Not yet recruiting NCT05754762 - Median Effective Dose of Remifentanil for the Prevention of Myoclonus Induced by Etomidate Injection N/A
Completed NCT00244361 - Effectiveness of Rituximab in Pediatric OMS Patients. Phase 1/Phase 2
Recruiting NCT05317390 - Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia N/A
Completed NCT00001663 - Treatment of Cortical Myoclonus With Repetitive Transcranial Magnetic Stimulation Phase 1
Recruiting NCT00029965 - Natural History of Glycosphingolipid Storage Disorders and Glycoprotein Disorders
Terminated NCT00506012 - Pilot Efficacy Study of T2000 in Myoclonus Dystonia Phase 2